Efficacy of oncolytic herpes virus G47. combined with immune checkpoint inhibitors in renal cell carcinoma models

被引：0
|
作者：
Sasaki, Kenichi [1 ,2 ]
Takeshima, Yuta [1 ]
Iwai, Miwako [1 ]
Fukuhara, Hiroshi [3 ]
Kume, Haruki [2 ]
Todo, Tomoki [1 ]
机构：
[1] IMSUT, Div Innovat Canc Therapy, Tokyo, Japan
[2] Univ Tokyo, Dept Urol, Fac Med, Tokyo, Japan
[3] Kyorin Univ, Sch Med, Dept Urol, Mitaka, Tokyo, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3371
引用
收藏
页码：1571 / 1571
页数：1
相关论文
共 50 条
  • [21] Combined effect of p53-armed oncolytic virus and immune checkpoint inhibitors in murine pancreatic cancer models
    Fujita, Shuto
    Tazawa, Hiroshi
    Kajiwara, Yoshinori
    Kikuchi, Satoru
    Kuroda, Shinji
    Noma, Kazuhiro
    Urata, Yasuo
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2025, 116 : 961 - 961
  • [22] Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Gao, Xin
    McDermott, David F.
    CANCER JOURNAL, 2018, 24 (04): : 171 - 179
  • [23] ENHANCED EFFICACY OF ONCOLYTIC HERPES SIMPLEX VIRUS (HSV-1) ARMED WITH IL-12 RENAL CELL CARCINOMA MODELS
    Fukuhara, Hiroshi
    Tsurumaki, Yuzuri
    Ino, Yasushi
    Todo, Tomoki
    Honma, Yukio
    JOURNAL OF UROLOGY, 2009, 181 (04): : 153 - 153
  • [24] Armed oncolytic myxoma virus demonstrates efficacy in syngeneic tumor models alone and in combination with immune checkpoint inhibitors.
    Franco, Lina S.
    Mamola, Joseph
    Abdullahi, Wazir
    De Matos, Ana
    Abrantes, Mario
    Walker, Benjamin S.
    Tacner, Zachary
    Grigaitis, Nicole
    Kien, Cassandra
    McFadden, Grant
    Sharp, Leslie L.
    CANCER RESEARCH, 2021, 81 (13)
  • [25] Effects of Immune Checkpoint Inhibitors on Histopathology of Renal Cell Carcinoma
    Setoodeh, Sasan
    Przybycin, Christopher
    Elias, Roy
    Rini, Brian
    Brugarolas, James
    Kapur, Payal
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 971 - 972
  • [26] Effects of Immune Checkpoint Inhibitors on Histopathology of Renal Cell Carcinoma
    Setoodeh, Sasan
    Przybycin, Christopher
    Elias, Roy
    Rini, Brian
    Brugarolas, James
    Kapur, Payal
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 971 - 972
  • [27] Enhanced efficacy of immune checkpoint inhibitors when used in combination with oncolytic HSV-1 G47Δ in lung cancer
    Sakata, Yoshinori
    Ino, Yasushi
    Iwai, Miwako
    Ikeda, Norihiko
    Todo, Tomoki
    CANCER SCIENCE, 2018, 109 : 917 - 917
  • [28] Efficacy of a Third-Generation Oncolytic Herpes Virus G47Δ in Advanced Stage Models of Human Gastric Cancer
    Sugawara, Kotaro
    Iwai, Miwako
    Yajima, Shoh
    Tanaka, Minoru
    Yanagihara, Kazuyoshi
    Seto, Yasuyuki
    Todo, Tomoki
    MOLECULAR THERAPY ONCOLYTICS, 2020, 17 : 205 - 215
  • [29] Combined Oncolytic Virotherapy with Herpes Simplex Virus for Oral Squamous Cell Carcinoma
    Ogawa, Fumi
    Takaoka, Hiroo
    Iwai, Soichi
    Aota, Keiko
    Yura, Yoshiaki
    ANTICANCER RESEARCH, 2008, 28 (6A) : 3637 - 3645
  • [30] Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
    Yamada, Tomoharu
    Tateishi, Ryosuke
    Iwai, Miwako
    Koike, Kazuhiko
    Todo, Tomoki
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 18 : 535 - 545
12345